We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
A filing was submitted.
An insider trade (Form 4) was filed.
An insider trade (Form 4) was filed.
A filing was submitted.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $99.75 · 3 analysts
Stored first · Google News · Yahoo Finance (English)
SYF Maintained by HSBC -- Price Target Raised to $97.00 - GuruFocus
SYF Maintained by HSBC -- Price Target Raised to $97.00 GuruFocus
HSBC Downgrades AstraZeneca(AZN.US) to Hold Rating, Cuts Target Price to $183.94 - 富途牛牛
HSBC Downgrades AstraZeneca(AZN.US) to Hold Rating, Cuts Target Price to $183.94 富途牛牛
HSBC Downgrade, Trial Setback Weigh on AstraZeneca - TradingPedia
HSBC Downgrade, Trial Setback Weigh on AstraZeneca TradingPedia
HSBC Adjusts Delta Air Lines Price Target to $113.50 From $109, Maintains Buy Rating
HSBC Downgrades AstraZeneca to Hold Rating, Cuts PT - marketscreener.com
HSBC Downgrades AstraZeneca to Hold Rating, Cuts PT marketscreener.com
AstraZeneca stock dips as HSBC downgrades stock on ’tough path ahead’
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | After market close (AMC) | $2.28 | — | — | $18.87B | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 12. 18. | Keefe, Bruyette & Woods | — | Upgrade | Market Perform → Outperform | — | Keefe, Bruyette & Woods: Market Perform → Outperform |
| 2025. 12. 11. | B of A Securities | — | Upgrade | Neutral → Buy | — | B of A Securities: Neutral → Buy |
| 2025. 10. 10. | Jefferies | — | Downgrade | Buy → Hold | — | Jefferies: Buy → Hold |
| 2025. 03. 04. | Barclays | — | Upgrade | Equal-Weight → Overweight | — | Barclays: Equal-Weight → Overweight |
| 2024. 03. 27. | Barclays | — | Downgrade | Overweight → Equal-Weight | — | Barclays: Overweight → Equal-Weight |
| 2022. 08. 04. | Goldman Sachs | — | Downgrade | Buy → Neutral | — | Goldman Sachs: Buy → Neutral |
Price data
No holdings data to show.